FindTrial
Sign In

To Understand the MIASMATIC aspect of the different cases of Alopecia and the efficacy of the Homoeopathic Anti-Miasmatic medicines according to the Miasm of the each individual patient

Miasmatic Diagnosis and Homoeopathic Management of Alopecia - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/12/098871
Enrollment
30
Registered
2025-12-11
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L63- Alopecia areata Health Condition 2: L64- Androgenic alopecia Health Condition 3: L65- Other nonscarring hair loss

Interventions

Intervention1: Homoeopathic Anti-Miasmatic medicines: Homoeopathic Anti-Miasmatic medicines will be administered by oral route to the patients according to their miasms. The potencies will be 200, 1M,

Sponsors

Dr Hinal Bhanubhai Mistry
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients, not on active allopathic treatment, or those who have stopped conventional treatment at least 3 weeks before enrollment. 2. Patients who can regularly report for follow-ups over the required study duration.

Exclusion criteria

Exclusion criteria: 1. SECONDARY AOPECIA- HAIR LOSS DUE TO BURNS, SCARRING, TRAUMA AND SURGERY. 2. ALOPECIA DUE TO AUTOIMMUNE DISEASES. 3. SEVERE PSYCHIATRIC DISORDES- PATIENTS ARE UNABLE TO GIVE RELIABLE HISTORY OR CONSENT.

Design outcomes

Primary

MeasureTime frame
Measure Yourself Medical Outcome Profile (MYMOP)Timepoint: At baseline and at the end of Treatment as per requirement of the case—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactDr Ranjit Singh Bedwan

Baroda Homoeopathic Medical college and Hospital

rsbedwan@gmail.com9825027298

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026